NovaBay Pharmaceuticals Statistics
Total Valuation
NBY has a market cap or net worth of $21.72 million. The enterprise value is $17.42 million.
Important Dates
The last earnings date was Thursday, August 14, 2025, after market close.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NBY has 5.82 million shares outstanding. The number of shares has increased by 953.24% in one year.
| Current Share Class | 5.82M |
| Shares Outstanding | 5.82M |
| Shares Change (YoY) | +953.24% |
| Shares Change (QoQ) | +7.44% |
| Owned by Insiders (%) | 0.01% |
| Owned by Institutions (%) | 3.76% |
| Float | 4.80M |
Valuation Ratios
The trailing PE ratio is 9.37.
| PE Ratio | 9.37 |
| Forward PE | n/a |
| PS Ratio | 2.18 |
| Forward PS | 1.67 |
| PB Ratio | 5.12 |
| P/TBV Ratio | 5.12 |
| P/FCF Ratio | 8.07 |
| P/OCF Ratio | 8.06 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 7.51 |
| EV / Sales | 1.78 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 6.47 |
Financial Position
The company has a current ratio of 2.85, with a Debt / Equity ratio of 0.25.
| Current Ratio | 2.85 |
| Quick Ratio | 2.52 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.39 |
| Interest Coverage | -22.72 |
Financial Efficiency
Return on equity (ROE) is -413.78% and return on invested capital (ROIC) is -105.88%.
| Return on Equity (ROE) | -413.78% |
| Return on Assets (ROA) | -65.27% |
| Return on Invested Capital (ROIC) | -105.88% |
| Return on Capital Employed (ROCE) | -118.69% |
| Revenue Per Employee | $698,643 |
| Profits Per Employee | $165,643 |
| Employee Count | 14 |
| Asset Turnover | 1.81 |
| Inventory Turnover | 5.66 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +683.28% in the last 52 weeks. The beta is 0.63, so NBY's price volatility has been lower than the market average.
| Beta (5Y) | 0.63 |
| 52-Week Price Change | +683.28% |
| 50-Day Moving Average | 0.93 |
| 200-Day Moving Average | 0.69 |
| Relative Strength Index (RSI) | 82.87 |
| Average Volume (20 Days) | 20,770,056 |
Short Selling Information
The latest short interest is 76,296, so 1.31% of the outstanding shares have been sold short.
| Short Interest | 76,296 |
| Short Previous Month | 38,260 |
| Short % of Shares Out | 1.31% |
| Short % of Float | 1.59% |
| Short Ratio (days to cover) | 1.86 |
Income Statement
In the last 12 months, NBY had revenue of $9.78 million and earned $2.32 million in profits. Earnings per share was $0.41.
| Revenue | 9.78M |
| Gross Profit | 6.48M |
| Operating Income | -5.66M |
| Pretax Income | -11.12M |
| Net Income | 2.32M |
| EBITDA | -5.63M |
| EBIT | -5.66M |
| Earnings Per Share (EPS) | $0.41 |
Full Income StatementBalance Sheet
The company has $5.34 million in cash and $1.04 million in debt, giving a net cash position of $4.30 million or $0.74 per share.
| Cash & Cash Equivalents | 5.34M |
| Total Debt | 1.04M |
| Net Cash | 4.30M |
| Net Cash Per Share | $0.74 |
| Equity (Book Value) | 4.25M |
| Book Value Per Share | 0.73 |
| Working Capital | 3.97M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $2.70 million and capital expenditures -$4,000, giving a free cash flow of $2.69 million.
| Operating Cash Flow | 2.70M |
| Capital Expenditures | -4,000 |
| Free Cash Flow | 2.69M |
| FCF Per Share | $0.46 |
Full Cash Flow StatementMargins
Gross margin is 66.26%, with operating and profit margins of -57.85% and 33.98%.
| Gross Margin | 66.26% |
| Operating Margin | -57.85% |
| Pretax Margin | -76.74% |
| Profit Margin | 33.98% |
| EBITDA Margin | -57.59% |
| EBIT Margin | -57.85% |
| FCF Margin | 27.51% |
Dividends & Yields
NBY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -953.24% |
| Shareholder Yield | -953.24% |
| Earnings Yield | 10.68% |
| FCF Yield | 12.39% |
Analyst Forecast
The average price target for NBY is $0.85, which is -77.21% lower than the current price. The consensus rating is "Strong Buy".
| Price Target | $0.85 |
| Price Target Difference | -77.21% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on May 31, 2024. It was a reverse split with a ratio of 1:35.
| Last Split Date | May 31, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:35 |
Scores
NBY has an Altman Z-Score of -35.91 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -35.91 |
| Piotroski F-Score | 6 |
